GA
ELV icon

Geneva Advisors’s Elevance Health ELV Stock Holding History

Geneva Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$86.5M Buy
459,777
+16,581
+4% +$2.98M 1.49% 14
2017
Q1 		$73.3M Buy
443,196
+673
+0.2% +$107K 1.31% 19
2016
Q4 		$63.6M Sell
442,523
-57,677
-12% -$7.72M 1.24% 24
2016
Q3 		$62.7M Buy
500,200
+124,831
+33% +$16.1M 1.18% 29
2016
Q2 		$49.3M Sell
375,369
-28,736
-7% -$3.93M 0.97% 35
2016
Q1 		$56.2M Buy
404,105
+99,284
+33% +$13.3M 1.13% 28
2015
Q4 		$42.5M Sell
304,821
-2,633
-0.9% -$363K 0.82% 42
2015
Q3 		$43M Sell
307,454
-114,988
-27% -$17.3M 0.87% 39
2015
Q2 		$69.3M Sell
422,442
-174,221
-29% -$27.8M 1.24% 29
2015
Q1 		$92.1M Sell
596,663
-36,228
-6% -$5.16M 1.67% 12
2014
Q4 		$79.5M Buy
632,891
+195,392
+45% +$24.1M 1.48% 17
2014
Q3 		$52.3M Buy
437,499
+47,288
+12% +$5.42M 0.99% 38
2014
Q2 		$42M Buy
390,211
+19,081
+5% +$1.97M 0.76% 53
2014
Q1 		$36.9M Buy
371,130
+6,077
+2% +$550K 0.68% 58
2013
Q4 		$33.7M Buy
365,053
+5,003
+1% +$445K 0.62% 63
2013
Q3 		$30.1M Buy
+360,050
New +$30.9M 0.62% 60

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geneva Advisors's ELV Position: Q2 2017 in Review

Geneva Advisors increased its Elevance Health (ELV) stake by 3.7% in Q2 2017, buying an estimated $2.98M and bringing the position to 459,777 shares worth $86.5M. The position accounts for 1.49% of the portfolio, ranked #14.

Geneva Advisors first reported a position in ELV in Q3 2013 and has held it in 16 quarters since. The position peaked at $92.1M in Q1 2015. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Geneva Advisors held 459,777 shares of Elevance Health worth $86.5M as of Q2 2017.
  • Geneva Advisors bought 16,581 Elevance Health shares in Q2 2017, an estimated $2.98M.
  • Elevance Health made up 1.49% of Geneva Advisors's portfolio in Q2 2017, its #14 holding.
  • Geneva Advisors first reported a position in Elevance Health in Q3 2013 and has held it in 16 quarters since.
  • Geneva Advisors's Elevance Health position peaked at $92.1M in Q1 2015.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.